Anagliptin (INN; trade name Suiny) is a pharmaceutical drug for the treatment of type 2 diabetes mellitus. It is approved for use in Japan. It belongs...
3 KB (161 words) - 00:49, 5 January 2023
Orforglipron§ Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins" Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin Melogliptin...
66 KB (5,418 words) - 18:14, 27 May 2024
anacetrapib (USAN, INN) Anacin-3 Anadrol-50 Anafranil anagestone (INN) anagliptin (INN) anagrelide (INN) Anaids Tablet anakinra (INN) Analpram-HC AnaMantle...
7 KB (420 words) - 06:24, 1 June 2024
(approved in Korea in 2012, marketed by LG Life Sciences) Marketed as Zemiglo Anagliptin (approved in Japan as Suiny in 2012, marketed by Sanwa Kagaku Kenkyusho...
16 KB (1,798 words) - 07:40, 1 February 2024
Orforglipron§ Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins" Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin Melogliptin...
3 KB (184 words) - 21:41, 23 May 2024
Orforglipron§ Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins" Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin Melogliptin...
26 KB (3,369 words) - 09:40, 17 May 2024
Orforglipron§ Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins" Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin Melogliptin...
36 KB (3,979 words) - 00:47, 14 May 2024
Orforglipron§ Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins" Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin Melogliptin...
4 KB (262 words) - 03:35, 22 March 2024
Orforglipron§ Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins" Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin Melogliptin...
142 KB (13,792 words) - 10:28, 23 May 2024
Orforglipron§ Semaglutide Taspoglutide† DPP-4 inhibitors/"gliptins" Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin Melogliptin...
20 KB (1,622 words) - 15:05, 11 April 2024